BM-MSCs isolated from SSc patients have upregulation of α-smooth muscle actin (SMA) and smooth muscle (SM)22α genes and reduced proliferative activity, displaying a more mature and myofibroblast-like phenotype. Here, SMN1 is linked to systemic sclerosis.